View Press Releases

Miltenyi Biotec Receives FDA Approval for CliniMACS® CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia

BERGISCH GLADBACH, GERMANY - Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease (GVHD) in patients with acute myeloid leukemia (AML) in first complete remission undergoing allogeneic stem cell transplantation (SCT) from a matched related donor
Feb 25, 2014
Insight Pharma Reports Announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community

NEEDHAM, MA - Cambridge Healthtech Institute's Insight Pharma Reports announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community.
Nov 30, 2013